Results 101 to 110 of about 2,141 (187)

Long-Term Efficacy, Predictors of Response, and Safety of Abrocitinib in Atopic Dermatitis: A Prospective Real-World Study

In this dataset, we have provided supplementary information for the study titled "Long-Term Efficacy, Predictors of Response, and Safety of Abrocitinib in Atopic Dermatitis: A Prospective Real-World Study." The supplementary materials include ...
YUEMENG, WU
core   +1 more source

A novel topical formulation with anti-inflammatory potential for localized abrocitinib delivery to atopic dermatitis skin

Oral abrocitinib is an effective treatment for atopic dermatitis (AD), but its use may be limited by systemic adverse effects. This study aimed to develop and evaluate a novel liposomes-in-hydrogel system for topical delivery of abrocitinib with the goal
Andrea Heinz, Natasa Skalko-Basnet, Iva Pitelkova, Madeleine Solvik, Øystein Grimstad, Maddhusja Nalliah   +5 more
core   +1 more source

Clinical and inflammatory determinants of successful abrocitinib dose reduction in atopic dermatitis: a real-world cohort study with implications for treatment optimization. [PDF]

Ann Med
Wang Y, Qin H, Gao Y, Li Z, Wu Y, Yin H, Wang S, Yao X, Wu H, Gu C.   +9 more
europepmc   +1 more source

Efficacy and safety of the JAK1 inhibitor abrocitinib for moderate-to-severe atopic dermatitis: a systematic review and meta-analysis. [PDF]

Front Pharmacol
Ning B, Li B, Luo Q, Song P.
europepmc   +1 more source

Abrocitinib for pediatric Toxicodendron contact dermatitis. [PDF]

JAAD Case Rep
Duan L, Wu X.
europepmc   +1 more source

Two-year abrocitinib in atopic dermatitis: Are we reaching the new targets? [PDF]

J Eur Acad Dermatol Venereol
De Greef A, Baeck M.
europepmc   +1 more source

Abrocitinib as a Novel Treatment for Multiple Skin Disorders: 3 Case Reports and a Scoping Review

Clinical, Cosmetic and Investigational Dermatology
Pingjiao Chen,1,* Jingyao Liang,2,3,* Changxing Li,1 Qian Li,2,3 Wenyan Liu,2,3 Junhui Zhu,2,3 Weifeng Chen,2,3 Xibao Zhang2,3 1Department of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People’s Republic of ...
Chen P, Liang J, Li C, Li Q, Liu W, Zhu J, Chen W, Zhang X   +7 more
doaj  

Optimizing Abrocitinib Use for Atopic Dermatitis in India: Expert Recommendations for Patient Selection, Dosing, and Long‑Term Remission. [PDF]

Clin Cosmet Investig Dermatol
Kandhari S, De A, Shankar K, G R, Pereira R, Jagadeesan S, Panda M, Singh V, Chakravadhanula U, Banodkar P.   +9 more
europepmc   +1 more source

A Case of Persistent Pityriasis Rosea Successfully Treated by a Short Course of Therapy with Abrocitinib [PDF]

Hao Wu, Qing-Jie Ji, Yu-Yang Xu, Jian-Wei Zhu Department of Dermatology, Quzhou TCM Hospital at the Junction of Four Provinces Affiliated to Zhejiang Chinese Medical University, Quzhou, People’s Republic of ChinaCorrespondence: Jian-Wei Zhu, Email zjwmed@
Zhu JW, Ji QJ, Xu YY, Wu H
core  

Epidermolysis bullosa pruriginosa: A retrospective cohort study highlighting secondary cutaneous amyloidosis and response to Janus kinase inhibition. [PDF]

JAAD Int
Hou PC, Cheng HC, Wu CL, Yang CC, Chao SC, Lee JY, Hsu CK.   +6 more
europepmc   +1 more source